2 completed, 2 recruiting, 1 withdrawn. 4 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Gordon Schanzlin New Vision: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effectiveness of Systane PRO Preservative Free Verses Blink Triple Care Preservative Free Systane PRO, Blink tears - Dry Eye Disease (DED) | Phase 4 | Recruiting | Gordon Schanzlin New Vision | 30 | 2026-07-17 | 2026-08-04 |
| Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses DAILIES TOTAL1 Multifocal (delefilcon A) - Contact Lens Comfort and Successful Refitting, Presbyopia | Not applicable | Recruiting | Gordon Schanzlin New Vision | 30 | 2026-05-20 | 2026-06-11 |
| Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease Systane Pro Topical Ophthalmic - Dry Eye Disease (DED) | Phase 4 | Completed | Gordon Schanzlin New Vision | 33 | 2025-11-01 | 2026-06-17 |
| Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers Miebo - Dry Eye, Dry Eye, Evaporative | Phase 4 | Completed | Gordon Schanzlin New Vision | 49 | 2023-09-21 | 2024-04-09 |
| Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses AGN-190584 - Presbyopia | Phase 4 | Withdrawn | Gordon Schanzlin New Vision | 2022-12-01 | 2024-04-09 |
Dry Eye Syndromes (3) · Presbyopia (2)
Polyethylene Glycols (1) · perfluorohexyl-octan (1)
United States (4)